Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Oxford Immunotec Global PLC | ex31-1.htm |
| EX-32 - EXHIBIT 32 - Oxford Immunotec Global PLC | ex32.htm |
| EX-31.2 - EXHIBIT 31.2 - Oxford Immunotec Global PLC | ex31-2.htm |
| EX-21.1 - EXHIBIT 21.1 - Oxford Immunotec Global PLC | ex21-1.htm |
| EX-10.36 - EXHIBIT 10.36 - Oxford Immunotec Global PLC | ex10-36.htm |
| EX-10.41 - EXHIBIT 10.41 - Oxford Immunotec Global PLC | ex10-41.htm |
| EX-10.44 - EXHIBIT 10.44 - Oxford Immunotec Global PLC | ex10-44.htm |
| 10-K - FORM 10-K - Oxford Immunotec Global PLC | oxfd20151231_10k.htm |
| EX-10.39 - EXHIBIT 10.39 - Oxford Immunotec Global PLC | ex10-39.htm |
| EX-10.43 - EXHIBIT 10.43 - Oxford Immunotec Global PLC | ex10-43.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-192582) pertaining to the Amended and Restated 2008 Stock Incentive Plan of Oxford Immunotec Global PLC, the Registration Statement (Form S-8 No. 333-193730) pertaining to the Oxford Immunotec Global PLC 2013 Share Incentive Plan, and the Registration Statement (Form S-3 No. 333-200571) of our report dated March 1, 2016 with respect to the consolidated financial statements of Oxford Immunotec Global PLC included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
/s/ Ernst & Young LLP
Reading, United Kingdom
March 1, 2016